To date, enhanced PRMT1 expression has been well documented in a variety of cancers, including lung cancer, and is correlated with a poor prognosis of tumor development through its promotion on tumor cell growth, proliferation, invasion, and metastasis (Wang et al., 20211004; Wang et al., 2021; Yao et al., 2021; Yin et al., 2021; Hua et al., 2020; Repenning et al., 2021). The gene discussed is PRMT1; the disease is lung cancer.